Dr. Joseph T Beck
Claim this profileHighlands Oncology Group
Studies Breast Cancer
Studies Cancer
15 reported clinical trials
37 drugs studied
Area of expertise
1Breast Cancer
HER2 negative
Stage IV
HR positive
2Cancer
Stage IV
PD-L1 positive
Stage II
Affiliated Hospitals
Clinical Trials Joseph T Beck is currently running
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
LP-184
for Solid Tumors
The primary objective of this study is to evaluate the safety, tolerability, MTD and RP2D of LP-184 in patients with advanced solid tumors who have relapsed from or are refractory to standard therapy or for whom no standard therapy is available. The secondary objectives are to characterize the PK of LP-184 and its metabolites in plasma and assess clinical activity of LP-184.
Recruiting1 award Phase 15 criteria
More about Joseph T Beck
Clinical Trial Related7 years of experience running clinical trials · Led 15 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Joseph T Beck has experience with
- Nivolumab
- Abemaciclib
- Relatlimab
- Ipilimumab
- Placebo
- Nivolumab-relatlimab FDC
Breakdown of trials Joseph T Beck has run
Breast Cancer
Cancer
Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Joseph T Beck specialize in?
Joseph T Beck focuses on Breast Cancer and Cancer. In particular, much of their work with Breast Cancer has involved HER2 negative patients, or patients who are Stage IV.
Is Joseph T Beck currently recruiting for clinical trials?
Yes, Joseph T Beck is currently recruiting for 6 clinical trials in Rogers Arkansas. If you're interested in participating, you should apply.
Are there any treatments that Joseph T Beck has studied deeply?
Yes, Joseph T Beck has studied treatments such as Nivolumab, Abemaciclib, Relatlimab.
What is the best way to schedule an appointment with Joseph T Beck?
Apply for one of the trials that Joseph T Beck is conducting.
What is the office address of Joseph T Beck?
The office of Joseph T Beck is located at: Highlands Oncology Group, Rogers, Arkansas 72758 United States. This is the address for their practice at the Highlands Oncology Group.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.